Was a Drop in CRISPR Firms’ Stock Warranted? – The Scientist
The Scientist |
Was a Drop in CRISPR Firms' Stock Warranted?
The Scientist ISTOCK, VCHALLast week, a study made headlines worldwide with its claim that the CRISPR-Cas9 genome-editing technique is more error prone than expected. In response, some investors chose to sell their shares in CRISPR-based biotech firms and stock … Someday, Maybe |
